133 related articles for article (PubMed ID: 7295339)
41. A new multifunctional hydroxytyrosol-clofibrate with hypolipidemic, antioxidant, and hepatoprotective effects.
Xie YD; Chen ZZ; Shao LH; Wang QT; Li N; Lu WF; Xu YH; Gao YQ; Guo LY; Liu HL; Li YP; Yang GD; Bian XL
Bioorg Med Chem Lett; 2018 Oct; 28(18):3119-3122. PubMed ID: 30119959
[TBL] [Abstract][Full Text] [Related]
42. A subcellular study of the clofibrate-induced increase in coenzyme A concentration in rat liver.
Voltti H; Hassinen IE
Biochem Pharmacol; 1980 Apr; 29(7):987-92. PubMed ID: 7387725
[No Abstract] [Full Text] [Related]
43. Procainamide N-acetyltransferase: modulation by clofibrate and a microsomal form.
Kang ES; Deaton PR; Epstein D; Ingram LA; Mirvis DM
Gen Pharmacol; 1989; 20(2):223-7. PubMed ID: 2469619
[TBL] [Abstract][Full Text] [Related]
44. Increased liver-specific expression of catalase in transgenic mice.
Nilakantan V; Li Y; Spear BT; Glauert HP
Ann N Y Acad Sci; 1996 Dec; 804():542-53. PubMed ID: 8993572
[No Abstract] [Full Text] [Related]
45. Hypolipidemic effects of dietary 7-oxo-24,25-dihydrolanosterol.
Sonoda Y; Sato Y
J Pharmacobiodyn; 1985 Jul; 8(7):518-24. PubMed ID: 4067814
[TBL] [Abstract][Full Text] [Related]
46. A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver.
Elwood JC; Richert DA; Westerfeld WW
Biochem Pharmacol; 1972 Apr; 21(8):1127-34. PubMed ID: 5034198
[No Abstract] [Full Text] [Related]
47. Hypolipidemic 4,5-dihydro-4-oxo-5,5-disubstituted-2-furancarboxylic acids.
Jirkovsky I; Cayen MN
J Med Chem; 1982 Oct; 25(10):1154-6. PubMed ID: 7143351
[No Abstract] [Full Text] [Related]
48. Induction of peroxisomal enzymes in rat liver by the hypolipidemic agent LK-903.
Hayashi H; Hino S; Yamasaki F; Watanabe T; Suga T
Biochem Pharmacol; 1981 Jul; 30(13):1817-22. PubMed ID: 7271869
[No Abstract] [Full Text] [Related]
49. Hypolipidemic and glycogenolytic effect of clofibrate (CPIB) in hypothyroid mice: role of insulin and glucagon.
Raheja KL; Linscheer WG; Patel DG
Gen Pharmacol; 1982; 13(1):49-52. PubMed ID: 7037529
[TBL] [Abstract][Full Text] [Related]
50. Effect of AY-25,712 and other lipid-lowering agents on liver catalase and liver carnitine acetyltransferase in rats.
Kallai-Sanfacon MA; Cayen MN; Dubuc J; Greselin E; Dvornik D
Proc Soc Exp Biol Med; 1983 Jul; 173(3):367-71. PubMed ID: 6867010
[TBL] [Abstract][Full Text] [Related]
51. Intraparticulate localization and some properties of a clofibrate-induced peroxisomal aldehyde dehydrogenase from rat liver.
Antonenkov VD; Pirozhkov SV; Panchenko LF
Eur J Biochem; 1985 May; 149(1):159-67. PubMed ID: 3996398
[TBL] [Abstract][Full Text] [Related]
52. Hepatic effect of two hypolipidemic drugs in rats.
Magnusson G; Magnusson O
Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of choline dehydrogenase activity in rat liver mitochondria by clofibrate feeding.
Kramar R; Kremser K; Raab R
Hoppe Seylers Z Physiol Chem; 1984 Oct; 365(10):1207-10. PubMed ID: 6394466
[TBL] [Abstract][Full Text] [Related]
54. Effects of clofibric acid and tiadenol on cytosolic long-chain acyl-CoA hydrolase and peroxisomal beta-oxidation in liver and extrahepatic tissues of rats.
Katoh H; Kawashima Y; Watanuki H; Kozuka H; Isono H
Biochim Biophys Acta; 1987 Jul; 920(2):171-9. PubMed ID: 2886154
[TBL] [Abstract][Full Text] [Related]
55. Increased cholesterol epoxide hydrolase activity in clofibrate-fed animals.
Finley BL; Hammock BD
Biochem Pharmacol; 1988 Aug; 37(16):3169-75. PubMed ID: 3401248
[TBL] [Abstract][Full Text] [Related]
56. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
Muroya Y; Ito O
Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064
[TBL] [Abstract][Full Text] [Related]
57. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
[TBL] [Abstract][Full Text] [Related]
58. Alterations by peroxisome proliferators of acyl composition of hepatic phosphatidylcholine in rats, mice and guinea-pigs. Role of stearoyl-CoA desaturase.
Kawashima Y; Hirose A; Kozuka H
Biochem J; 1986 Apr; 235(1):251-5. PubMed ID: 2874791
[TBL] [Abstract][Full Text] [Related]
59. Prevention of CeCl3-induced hepatotoxicity by hypolipidemic compounds.
Tuchweber B; Salas M
Arch Toxicol; 1978 Dec; 41(3):223-32. PubMed ID: 736793
[TBL] [Abstract][Full Text] [Related]
60. Effect of clofibrate on lipid peroxidation in rats treated with aspirin and 4-pentenoic acid.
Nakagawa M; Ishihara N; Shimokawa T; Kojima S
J Biochem; 1987 Jan; 101(1):81-8. PubMed ID: 3571211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
